This compound is primarily utilized in the field of medicinal chemistry as a key intermediate in the synthesis of various pharmaceutical agents. It is particularly significant in the development of compounds targeting neurological and psychiatric disorders. The morpholine ring and amine functional group in its structure make it a versatile building block for designing molecules that interact with neurotransmitter systems. Additionally, it has been explored in the creation of potential treatments for conditions such as depression, anxiety, and cognitive impairments due to its ability to modulate receptor activity in the brain. Its dihydrochloride form enhances solubility, making it more suitable for formulation in drug development processes.